In addition, elevated levels of both free (>24 ng/ml) and vesicle-bound (>15 ng/ml) sHLA-G were associated with unfavourable clinical outcomes after NACT90.
König et al.90 demonstrated a direct link between HLA-G levels, the presence of CTCs, and clinical outcomes of patients with breast cancer after neoadjuvant chemotherapy (NACT): high pre-NACT plasma levels of sHLA-G in extracellular vesicles, but not free sHLA-G, were associated with the presence of stem-cell-like CTCs and disease progression.
Despite this, only 4% of deaths among low birth weight infants (all <1500 g) were associated with care decisions at non tertiary centers; none of these deaths involved intentional inappropriate retention of infants or mothers.
Three SNPs (-278 A/G, Val/Met and rs165599 A/ G) were associated in this broad diagnostic group with -278 A/G showing the most significant p-values.
In univariate analysis, meningitis and very low birthweight (<1,500 g) were associated with a higher overall CFR (p = 0.002 and p = 0.003, respectively).
Results of haplotype analysis showed that 4 haplotypes which contained rs9364559-G were associated with increased risk of CAD in this population.
Our findings showed that delivering a baby with a birth weight ≥ 3500 g was associated with dystocia at term without any association with exposure of violence.
We report an association to age for rs6983267 on 8q24.21; the risk allele G was associated to our older patients (P=0.0014).
Conclusion: Birth weight ≥4000 g is associated with more than a two-fold increased risk of an unplanned Caesarean delivery.
HLA-G is highly expressed in numerous malignancies, including melanoma, glioma, and colorectal, hepatocellular, breast, lung, and ovarian cancers82,83,84,85,86; expression of HLA-G is associated with poor patient survival and has been confirmed as independent prognostic factor82,83,84,85.
